Wexford Capital’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $159K | Sell |
81,590
-691,329
| -89% | -$1.35M | 0.04% | 187 |
|
|
2025
Q1 | $1.36M | Sell |
772,919
-173,300
| -18% | -$305K | 0.35% | 59 |
|
|
2024
Q4 | $2.52M | Buy |
946,219
+294,452
| +45% | +$783K | 0.4% | 37 |
|
|
2024
Q3 | $1.49M | Buy |
651,767
+588,500
| +930% | +$1.35M | 0.36% | 53 |
|
|
2024
Q2 | $185K | Buy |
63,267
+37,982
| +150% | +$111K | 0.05% | 178 |
|
|
2024
Q1 | $92K | Buy |
25,285
+11,288
| +81% | +$41.1K | 0.02% | 206 |
|
|
2023
Q4 | $21.1K | Sell |
13,997
-25,105
| -64% | -$37.9K | ﹤0.01% | 191 |
|
|
2023
Q3 | $52.4K | Buy |
39,102
+13,402
| +52% | +$18K | 0.01% | 179 |
|
|
2023
Q2 | $46.3K | Sell |
25,700
-71,938
| -74% | -$129K | 0.01% | 183 |
|
|
2023
Q1 | $162K | Buy |
97,638
+74,638
| +325% | +$124K | 0.03% | 174 |
|
|
2022
Q4 | $44.2K | Buy |
+23,000
| New | +$44.2K | 0.01% | 129 |
|